Outlook Therapeutics annual operating margin
2015
2016
2017
2018
2019
2025
Outlook Therapeutics Operating Margin Growth & History (OTLK)
Outlook Therapeutics's operating margin was −4,744.25% for fiscal 2025.
View full Outlook Therapeutics company overviewOutlook Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-09-30 | −4,744.25% | — |
| 2019 | 2019-09-30 | −445.60% | +514.52 pp |
| 2018 | 2018-09-30 | −960.12% | −18.76 pp |
| 2017 | 2017-09-30 | −941.36% | +781.94 pp |
| 2016 | 2016-09-30 | −1,723.30% | −831.17 pp |
| 2015 | 2015-09-30 | −892.13% | — |
Outlook Therapeutics quarterly operating margin
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q3.25
Q2.26
Q3.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2026 | 2026-06-30 | −124,255.28% | −123209.08 pp |
| Q2 2026 | 2026-03-31 | −11,006.82% | — |
| Q3 2025 | 2025-06-30 | −1,046.20% | — |
| Q4 2019 | 2019-09-30 | −216.83% | +1391.39 pp |
| Q3 2019 | 2019-06-30 | −966.72% | −31.37 pp |
| Q2 2019 | 2019-03-31 | −1,201.86% | −316.89 pp |
| Q1 2019 | 2018-12-31 | −960.78% | −548.84 pp |
| Q4 2018 | 2018-09-30 | −1,608.21% | −1507.92 pp |
| Q3 2018 | 2018-06-30 | −935.35% | +1484.79 pp |
| Q2 2018 | 2018-03-31 | −884.97% | +1700.63 pp |
| Q1 2018 | 2017-12-31 | −411.95% | +5458.36 pp |
| Q4 2017 | 2017-09-30 | −100.29% | +1910.74 pp |
| Q3 2017 | 2017-06-30 | −2,420.14% | +2030.81 pp |
| Q2 2017 | 2017-03-31 | −2,585.60% | −2288.69 pp |
| Q1 2017 | 2016-12-31 | −5,870.30% | −4220.56 pp |
| Q4 2016 | 2016-09-30 | −2,011.04% | — |
| Q3 2016 | 2016-06-30 | −4,450.95% | −3597.93 pp |
| Q2 2016 | 2016-03-31 | −296.91% | +2532.31 pp |
| Q1 2016 | 2015-12-31 | −1,649.75% | — |
| Q3 2015 | 2015-06-30 | −853.02% | — |
| Q2 2015 | 2015-03-31 | −2,829.23% | — |
Outlook Therapeutics operating margin trends
Between the periods ended 2015-09-30 and 2025-09-30, Outlook Therapeutics's operating margin decreased from −892.13% to −4,744.25%, a change of −3852.12 percentage points. The latest reported quarter, Q3 2026, shows −124,255.28%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Outlook Therapeutics source filings ↗